Glaucoma News

BOSTON — A sustained-release bimatoprost drug delivery platform shows promise in the treatment of ocular hypertension and open-angle glaucoma, according to a poster at the American Society of Cataract and Refractive Surgery meeting.

In January, the New Hampshire Senate received SB 440, a bill that would expand optometry’s scope of practice in the state to include minor eye surgeries, including several using lasers.

BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Matt Link, chief commercial officer of Sight Sciences, shares information on the company’s clinical trials.

BOSTON — Phacoemulsification plus minimally invasive glaucoma surgery improves quality of life and prevents visual field loss in patients with glaucoma, according to a speaker.

Patients with glaucoma who underwent cataract surgery in combination with the Omni surgical system had lower IOP and used fewer medications at 24 months compared with outcomes with other devices, according to a study.

Higher consumption of ultraprocessed foods, particularly sweets, was associated with an increased risk for glaucoma, a study published in Nutrients showed.

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Cody McKenzie of Glaukos discusses the anticipated impact of the iDose TR, which launched during the meeting.

BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Pete England, vice president of global marketing at ViaLase, discusses the company’s femtosecond laser platform for the treatment of open-angle glaucoma.

TAMPA, Fla. — In a presentation from Telling It Like It Is, Analisa Arosemena, MD, discussed the path to achieving 24/7 IOP control for patients with glaucoma and the role that canaloplasty may play.

Qlaris Bio announced the initiation and dosing of two phase 2 trials aimed at assessing QLS-111, a therapy for lowering intraocular pressure by targeting episcleral venous pressure, or EVP, in patients with glaucoma.